Malini Iyengar

2.4k total citations
26 papers, 1.6k citations indexed

About

Malini Iyengar is a scholar working on Cardiology and Cardiovascular Medicine, Experimental and Cognitive Psychology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Malini Iyengar has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Experimental and Cognitive Psychology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Malini Iyengar's work include Blood Pressure and Hypertension Studies (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Perfectionism, Procrastination, Anxiety Studies (5 papers). Malini Iyengar is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Perfectionism, Procrastination, Anxiety Studies (5 papers). Malini Iyengar collaborates with scholars based in United States, United Kingdom and Netherlands. Malini Iyengar's co-authors include Vered Stearns, Katherine Beebe, Éric Dubé, Kevin M. Bellew, James P. McCafferty, Rocco Zaninelli, Daniel B. Burnham, Karl Rickels, David V. Sheehan and Andrew W. Goddard and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Malini Iyengar

26 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malini Iyengar United States 18 463 462 336 307 295 26 1.6k
J. Erickson United States 24 685 1.5× 391 0.8× 89 0.3× 455 1.5× 1.4k 4.9× 38 3.8k
Dominic Pilon United States 19 169 0.4× 146 0.3× 126 0.4× 132 0.4× 350 1.2× 166 1.8k
Rebecca D. Jackson United States 13 271 0.6× 78 0.2× 197 0.6× 57 0.2× 54 0.2× 17 1.4k
David D. Ørsted Denmark 20 1.1k 2.5× 69 0.1× 141 0.4× 80 0.3× 292 1.0× 32 2.4k
Phillip Banks United States 24 1.5k 3.2× 93 0.2× 456 1.4× 59 0.2× 241 0.8× 57 2.8k
Raffaele Pirozzi Italy 22 66 0.1× 170 0.4× 115 0.3× 348 1.1× 329 1.1× 35 2.1k
Robin E. Rutherford United States 16 62 0.1× 123 0.3× 162 0.5× 63 0.2× 174 0.6× 23 2.1k
J. B. Ruidavets France 17 218 0.5× 64 0.1× 74 0.2× 51 0.2× 34 0.1× 28 1.4k
S Rössner Sweden 19 449 1.0× 61 0.1× 70 0.2× 130 0.4× 192 0.7× 38 1.6k
Akshay Buch United States 16 1.2k 2.6× 53 0.1× 205 0.6× 226 0.7× 116 0.4× 34 1.8k

Countries citing papers authored by Malini Iyengar

Since Specialization
Citations

This map shows the geographic impact of Malini Iyengar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malini Iyengar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malini Iyengar more than expected).

Fields of papers citing papers by Malini Iyengar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malini Iyengar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malini Iyengar. The network helps show where Malini Iyengar may publish in the future.

Co-authorship network of co-authors of Malini Iyengar

This figure shows the co-authorship network connecting the top 25 collaborators of Malini Iyengar. A scholar is included among the top collaborators of Malini Iyengar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malini Iyengar. Malini Iyengar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stadtmauer, Edward A., Thomas Faitg, Daniel E. Lowther, et al.. (2019). Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma. Blood Advances. 3(13). 2022–2034. 69 indexed citations
2.
D’Angelo, Sandra P., Mihaela Druta, George D. Demetri, et al.. (2017). A pilot study of NY-ESO-1c259 T cells in subjects with advanced myxoid/round cell liposarcoma (NCT02992743).. Journal of Clinical Oncology. 35(15_suppl). TPS3097–TPS3097. 2 indexed citations
3.
Giannini, Edoardo G., Nezam H. Afdhal, Samuel H. Sigal, et al.. (2015). Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy. Journal of Gastroenterology and Hepatology. 30(8). 1301–1308. 4 indexed citations
4.
Bussel, James B., Purificación García de Miguel, Jenny M. Despotovic, et al.. (2015). Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. The Lancet Haematology. 2(8). e315–e325. 133 indexed citations
5.
Bakris, George L., Malini Iyengar, Mary Ann Lukas, Paul Ordronneau, & Michael A. Weber. (2010). Effect of Combining Extended‐Release Carvedilol and Lisinopril in Hypertension: Results of the COSMOS Study. Journal of Clinical Hypertension. 12(9). 678–686. 19 indexed citations
6.
Miller, Alan B., Nathaniel Reichek, Martin St. John Sutton, et al.. (2010). Importance of blood pressure control in left ventricular mass regression. Journal of the American Society of Hypertension. 4(6). 302–310. 19 indexed citations
7.
Loprinzi, Charles L., Jeff A. Sloan, Vered Stearns, et al.. (2009). Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis. Journal of Clinical Oncology. 27(17). 2831–2837. 128 indexed citations
8.
Rapaport, Mark Hyman, et al.. (2008). Low Doses of Controlled-Release Paroxetine in the Treatment of Late-Life Depression. The Journal of Clinical Psychiatry. 70(1). 46–57. 25 indexed citations
9.
10.
McGill, Janet B., George L. Bakris, Vivian Fonseca, et al.. (2007). β‐Blocker use and diabetes symptom score: results from the GEMINI study. Diabetes Obesity and Metabolism. 9(3). 408–417. 20 indexed citations
11.
Wright, Jackson T., George L. Bakris, David S.H. Bell, et al.. (2007). Lowering Blood Pressure With β‐Blockers in Combination With Other Renin‐Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial. Journal of Clinical Hypertension. 9(11). 842–849. 15 indexed citations
12.
Weber, Michael A., et al.. (2006). Efficacy of a Once‐Daily Formulation of Carvedilol for the Treatment of Hypertension. Journal of Clinical Hypertension. 8(12). 840–849. 29 indexed citations
13.
Rickels, Karl, et al.. (2006). Remission of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 67(1). 41–47. 57 indexed citations
14.
Weber, Michael A., et al.. (2006). Controlled-Release Carvedilol in the Treatment of Essential Hypertension. The American Journal of Cardiology. 98(7). 32–38. 31 indexed citations
15.
Bakris, George L., David S.H. Bell, Vivian Fonseca, et al.. (2005). The rationale and design of the Glycemic Effects in Diabetes Mellitus. Journal of Diabetes and its Complications. 19(2). 74–79. 13 indexed citations
16.
Sheehan, David V., et al.. (2005). Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder. The Journal of Clinical Psychiatry. 66(1). 34–40. 63 indexed citations
17.
Stocchi, Fabrizio, et al.. (2003). Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 64(3). 250–258. 91 indexed citations
18.
Stearns, Vered, Katherine Beebe, Malini Iyengar, & Éric Dubé. (2003). Paroxetine Controlled Release in the Treatment of Menopausal Hot Flashes. JAMA. 289(21). 2827–2827. 370 indexed citations
19.
Rickels, Karl, Rocco Zaninelli, James P. McCafferty, et al.. (2003). Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study. American Journal of Psychiatry. 160(4). 749–756. 145 indexed citations
20.
Pollack, Mark H., Rocco Zaninelli, Andrew W. Goddard, et al.. (2001). Paroxetine in the Treatment of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 62(5). 350–357. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Erickson Breakdown of academic impact, for papers by Dominic Pilon Breakdown of academic impact, for papers by Rebecca D. Jackson Breakdown of academic impact, for papers by David D. Ørsted Breakdown of academic impact, for papers by Phillip Banks Breakdown of academic impact, for papers by Raffaele Pirozzi Breakdown of academic impact, for papers by Robin E. Rutherford Breakdown of academic impact, for papers by J. B. Ruidavets Breakdown of academic impact, for papers by S Rössner Breakdown of academic impact, for papers by Akshay Buch
Rankless by CCL
2026